Tirzepatide + B12

Dual GLP-1/GIP weight management.

Tirzepatide is a dual GLP-1 and GIP receptor agonist prescribed for weight management. This is a compounded preparation that also contains vitamin B12.

How it works

Tirzepatide activates both GLP-1 and GIP receptors, which reduces appetite signalling and improves how the body handles glucose.

Benefits

• Weekly dual GLP-1 and GIP treatment
• Reduces appetite signalling
• Supports insulin sensitivity
• Supports glucose metabolism
• Physician-dosed and titrated

Dosing protocol

Start at 2.5mg weekly for 4 weeks, titrate up to 5mg, 7.5mg, 10mg, 12.5mg, or 15mg as tolerated. Weekly subcutaneous injection.

Contraindications

• Personal or family history of thyroid cancer
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pancreatitis
• Severe GI disease
• Pregnancy

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.